Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

FDA approves manufacturing change for BENAZEPRIL HYDROCHLORIDE

  • FDA Approval
  • Jan. 14, 2026, 23:09 UTC
  • 17
  • 0 comments

Manufacturing process update for AUROBINDO PHARMA. Submission: SUPPL-28. Decision date: 01/13/2026

Comment Full text

FDA approves LAMOTRIGINE from TORRENT

  • FDA Approval
  • Jan. 14, 2026, 23:09 UTC
  • 28
  • 0 comments

Final approval of ANDA #ANDA #217100 for LAMOTRIGINE. Decision date: 01/08/2026

Comment Full text

FDA updates labeling for OXYCODONE HYDROCHLORIDE

  • FDA Approval
  • Jan. 13, 2026, 09:37 UTC
  • 19
  • 0 comments

Labeling changes approved for VISTAPHARM LLC. Active ingredient: OXYCODONE HYDROCHLORIDE. Decision date: 01/06/2026

Comment Full text

FDA updates labeling for METHYLPHENIDATE HYDROCHLORIDE

  • FDA Approval
  • Jan. 13, 2026, 09:37 UTC
  • 16
  • 0 comments

Labeling changes approved for ABHAI LLC. Active ingredient: METHYLPHENIDATE HYDROCHLORIDE. Decision date: 01/09/2026

Comment Full text

FDA updates labeling for OXYCODONE HYDROCHLORIDE

  • FDA Approval
  • Jan. 13, 2026, 09:37 UTC
  • 16
  • 0 comments

Labeling changes approved for NOVEL LABS INC. Active ingredient: OXYCODONE HYDROCHLORIDE. Decision date: 01/06/2026

Comment Full text

FDA updates labeling for OXYCODONE HYDROCHLORIDE

  • FDA Approval
  • Jan. 13, 2026, 09:37 UTC
  • 17
  • 0 comments

Labeling changes approved for HIKMA. Active ingredient: OXYCODONE HYDROCHLORIDE. Decision date: 01/06/2026

Comment Full text

FDA approves FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE from RESPIRENT PHARMS

  • FDA Approval
  • Jan. 13, 2026, 09:37 UTC
  • 18
  • 0 comments

Final approval of ANDA #ANDA #214464 for FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE. Decision date: 01/12/2026

Comment Full text

FDA approves SUCRALFATE from GLENMARK PHARMS LTD

  • FDA Approval
  • Jan. 13, 2026, 09:37 UTC
  • 15
  • 0 comments

Final approval of ANDA #ANDA #212141 for SUCRALFATE. Decision date: 01/05/2026

Comment Full text

FDA approves EVEROLIMUS from BIOCON PHARMA

  • FDA Approval
  • Jan. 13, 2026, 05:11 UTC
  • 15
  • 0 comments

Final approval of ANDA #ANDA #217216 for EVEROLIMUS. Decision date: 01/09/2026

Comment Full text

FDA approves SAPROPTERIN DIHYDROCHLORIDE from MICRO LABS

  • FDA Approval
  • Jan. 13, 2026, 05:11 UTC
  • 14
  • 0 comments

Final approval of ANDA #ANDA #219511 for SAPROPTERIN DIHYDROCHLORIDE. Decision date: 01/08/2026

Comment Full text
  • 1
  • 2
  • 3
  • Next

Search

News categories

  • Technical Exchange News(10839)
  • Event(2204)
  • SEC News(187788)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124243)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin